IPP Bureau
Yoga day 2026 draws enthusiastic participation in Delhi
By IPP Bureau - June 22, 2026
The 12th International Day of Yoga is being observed across all States and Union Territories in India, as well as in more than 180 countries worldwide
Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
By IPP Bureau - June 22, 2026
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
By IPP Bureau - June 22, 2026
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
MICK Digital empanelled as AMTZ authorized channel partner
By IPP Bureau - June 22, 2026
Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks
Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift
By IPP Bureau - June 21, 2026
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
Lubrizol and Polyhose launch advanced medical tubing plant in Chennai
By IPP Bureau - June 21, 2026
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices
Univar expands EMEA reach in botanical ingredients push with American Distilling partnership
By IPP Bureau - June 21, 2026
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
By IPP Bureau - June 21, 2026
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
By IPP Bureau - June 21, 2026
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market
By IPP Bureau - June 20, 2026
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Alembic Pharma receives USFDA tentative approval for Binimetinib tablets
By IPP Bureau - June 20, 2026
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Manipal Hospitals Mukundapur launches advanced Neuro Biplane Cathlab
By IPP Bureau - June 20, 2026
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds
By IPP Bureau - June 20, 2026
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
By IPP Bureau - June 20, 2026
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Govt pushes for identifying every missing TB case
By IPP Bureau - June 20, 2026
Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline
